A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial)

BACKGROUND: Major depression is the second leading cause of years lost to disability worldwide and is a leading contributor to suicide. However, first-line antidepressants are only fully effective for 33%, and only 40% of those offered psychological treatment attend for two sessions or more. Views g...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shireen, Boutry, Clement, Patel, Priya, Craven, Michael P., Guo, Boliang, Zafar, Azhar, Kai, Joe, Smart, David, Butler, Debbie, Higton, Fred, McNaughton, Rebecca, Briley, Paul M., Griffiths, Chris, Nixon, Neil, Sayal, Kapil, Morriss, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978160/
https://www.ncbi.nlm.nih.gov/pubmed/35379314
http://dx.doi.org/10.1186/s13063-022-06192-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978160/
https://www.ncbi.nlm.nih.gov/pubmed/35379314
http://dx.doi.org/10.1186/s13063-022-06192-1

Ejemplares similares